Clinical outcomes among HR+/HER2− metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US

BACKGROUND: Hormone receptor-positive, human epidermal growth factor receptor-2-negative (HR+/HER2−) is the most common type of metastatic breast cancer (mBC). While mBC patients generally have poor prognosis with limited progression-free survival (PFS) and overall survival (OS), those with multiple...

詳細記述

保存先:
書誌詳細
出版年:Exp Hematol Oncol
主要な著者: Xie, Jipan, Hao, Yanni, Li, Nanxin, Lin, Peggy L., Ohashi, Erika, Koo, Valerie, Wu, Eric Q.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2015
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4676876/
https://ncbi.nlm.nih.gov/pubmed/26693096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-015-0023-0
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料